Drug combination
Showing 1 - 25 of >10,000
Uncomplicated Plasmodium Falciparum Malaria Trial in Bagamoyo (Artemether-lumefantrine and Amodiaquine Drug Combination,
Not yet recruiting
- Uncomplicated Plasmodium Falciparum Malaria
- Artemether-lumefantrine and Amodiaquine Drug Combination
- +2 more
-
Bagamoyo, Dar esSalaam, Tanzania
- +1 more
Feb 28, 2023
Congenital Adrenal Hyperplasia (CAH) Trial run by the NICHD (Flutamide, Letrozole, Hydrocortisone)
Active, not recruiting
- Congenital Adrenal Hyperplasia (CAH)
- Flutamide
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Uncomplicated Plasmodium Falciparum Trial in Tambolaka (Dihydroartemisinin, Piperaquine, Primaquine)
Completed
- Uncomplicated Plasmodium Falciparum
- Dihydroartemisinin
- +3 more
-
Tambolaka, East Nusa Tenggara, IndonesiaKori Puskesmas
Apr 27, 2023
Malaria Trial (Artemether-Lumefantrine Drug Combination, Dihydroartemisinin-Piperaquine drug combination)
Not yet recruiting
- Malaria
- Artemether-Lumefantrine Drug Combination
- Dihydroartemisinin-Piperaquine drug combination
- (no location specified)
Apr 15, 2022
A Combination Drug Including Fimasartan and Statins in
Completed
- Hypertension and Dyslipidemia
- Combination drug containing fimasartan and statins
-
Gwangju, Jebong-ro, Jangseong-eup, Jangseong-gun, Korea, Republic ofChonnam National University Hospital
Nov 15, 2022
Newly Diagnosed Glioblastoma Trial (combinations of up to 3 FDA approved drugs from a panel of compounds)
Not yet recruiting
- Newly Diagnosed Glioblastoma
- combinations of up to 3 FDA approved drugs from a panel of compounds
- (no location specified)
Jan 19, 2023
Huaier Granules in Postoperative Adjuvant Therapy for Non-small
Not yet recruiting
- Non-small Cell Lung Cancer
- Huaier granule
- Control
-
Shenyang, Liaoning, ChinaLiaoning Cancer Hospital & Institute
Oct 27, 2023
Pharmacokinetic, Healthy, Drug Combination Trial in Bangkok (Artemether-lumefantrine, Amodiaquine, Artemether-lumefantrine +
Recruiting
- Pharmacokinetic
- +2 more
- Artemether-lumefantrine
- +2 more
-
Bangkok, ThailandFaculty of Tropical Medicine, Mahidol University
Nov 11, 2022
Drug-drug Interaction Study Trial in Hyderabad (SPRYCEL® (dasatinib) 100 mg Film-Coated Tablets in combination with Omeprazole
Completed
- Drug-drug Interaction Study
- SPRYCEL® (dasatinib) 100 mg Film-Coated Tablets in combination with Omeprazole Delayed-Release Capsules USP, 40 mg
-
Hyderabad, IndiaQPS Bioserve India Pvt Limited
Nov 20, 2023
Non-healing Wound, Non-Healing Ulcer of Skin Trial in Santa Fe (Omeza Products Used in Combination)
Recruiting
- Non-healing Wound
- Non-Healing Ulcer of Skin
- Omeza Products Used in Combination
-
Santa Fe, New MexicoChristus St. Vincent
Jun 19, 2023
Monitoring Drug Efficacy in Patients With Alzheimer's Disease
Recruiting
- Alzheimer Disease
- AChE inhibitor monotherapy
- AChE inhibitor and NMDA receptor antagonist combination therapy
-
Manila, Metro Manila, PhilippinesPhilippine General Hospital
Mar 24, 2023
Coronary Artery Disease Trial in Milano (DES+DCB)
Enrolling by invitation
- Coronary Artery Disease
- DES+DCB
-
Milano, ItalyIstituto Clinico S.Ambrogio
Dec 4, 2022
Alcohol Use Disorder Trial in Lexington (Alcohol, Placebos, Duloxetine)
Recruiting
- Alcohol Use Disorder
- Alcohol
- +3 more
-
Lexington, KentuckyUniversity of Kentucky
Sep 23, 2022
COVID-19 Trial in Mansoura (Casirivimab and Imdevimab Drug Combination, Remdesivir, Favipiravir)
Completed
- COVID-19
- Casirivimab and Imdevimab Drug Combination
- +2 more
-
Mansoura, El-dkhalia, EgyptEl-gomhoria St
Aug 13, 2022
Malaria Trial (Ganaplacide, Lumefantrine, Efavirenz)
Completed
- Malaria
- Ganaplacide
- +2 more
-
Belfast, Northern Ireland, United KingdomNovartis Investigative Site
Jan 11, 2023
Coronary Artery Disease Requiring Coronary Revascularization With Newer Generation DES Implantation Trial in Seoul
Not yet recruiting
- Coronary Artery Disease Requiring Coronary Revascularization With Newer Generation DES Implantation
- ezetimibe/high-intensity statin combination therapy (ezetimibe 10mg plus atoravastatin 40mg)
- high-intensity statin monotherapy (atoravastatin 40mg)
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Mar 21, 2023
Multi-Drug Resistant Hiv-1 Infection, HIV-1 Infection Trial run by the National Institute of Allergy and Infectious Diseases
Not yet recruiting
- Multi-Drug Resistant Hiv-1 Infection
- HIV-1 Infection
- UB-421
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Bacterial Infections Trial (Xeruborbactam Oral Prodrug, Ceftibuten, Xeruborbactam Oral Prodrug Placebo)
Not yet recruiting
- Bacterial Infections
- Xeruborbactam Oral Prodrug
- +3 more
- (no location specified)
Oct 6, 2023
Lung Cancer Trial in Korea, Republic of (Olaparib+Bevacizumab to SCLC patients)
Recruiting
- Lung Cancer
- Olaparib+Bevacizumab to SCLC patients
-
Seoul, Gangnam-gu, Korea, Republic of
- +3 more
Nov 9, 2022
Periodontal Pocket Trial (silk fibroin, Chlorhexidin, combination of silk fibroin and chlorhexidine)
Not yet recruiting
- Periodontal Pocket
- silk fibroin
- +2 more
- (no location specified)
Sep 16, 2023
Ovarian Cancer Trial in Maywood (Decitabine, Carboplatin, Paclitaxel)
Not yet recruiting
- Ovarian Cancer
- Decitabine
- +3 more
-
Maywood, IllinoisLoyola University Medical Center
Aug 1, 2023
Tonsillectomy, Adenoidectomy, Drug-Related Side Effects and Adverse Reaction Trial in Cairo (The midazolam group, The midazolam
Recruiting
- Tonsillectomy
- +2 more
- The midazolam group
- The midazolam ketamine group
-
Cairo, EgyptCairo university hospitals, kasralainy
Nov 7, 2023
Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial in Edegem, Roeselare (Venetoclax, 6-mercaptopurine)
Recruiting
- Acute Myeloid Leukemia, in Relapse
- Acute Myeloid Leukemia Refractory
-
Edegem, Antwerp, Belgium
- +1 more
Aug 16, 2022